Joseph Straus, Md, Mba Email & Phone Number

Jerusalem Area, Israel

Imagine Bio focuses on investment development services and strategic business development services for medical innovation and high tech companies. We specialize in helping our clients present the best possible business case to investors and strategic partners.We also assist investors and multinationals in sourcing and assessing medical device, diagnostic, pharma, biotech and digital health opportunities. Our group operates globally with clients based in the US, EU, and Israel.

Israel

Raphael Medical was a medical and veterinary innovation consulting company which helped promising, very early stage- to mature companies streamline their development and commercialization efforts, raise investment capital and find strategic partners.

Proton Beam Therapy is a highly sophisticated form of external beam radiation therapy that targets cancers with an unparalleled degree of precision, safety and efficiency, while maximally sparing surrounding healthy tissue. The IPTI vision is for a state-of-the-art Proton Beam Therapy center in Israel that will partner with existing Israeli radiation therapy centers and (radiation) oncology experts, and will ensure the safe, effective and cost efficient delivery of this technology.

Raphael Medical initially provided patient advocacy services; helping patients with rare, complicated and serious medical conditions identify and gain access to top specialists and innovative, sophisticated and effective medical services.

The Healthcare Across Borders conferences served the private healthcare industry as international business development venues. The meetings were help in the Americas and in Europe. The conferences were supported by companies such as Aetna and Cigna, and attracted a diverse group of healthcare executives, business leaders, and representatives from academia.

Mallinckrodt Medical (today: Mallinckrodt Pharmaceuticals), is a global pharmaceutical and medical devices company. Key experiences and responsibilities: • The successful introduction in the US of OctreoScan, a first-in-class radio-pharmaceutical• Technology assessment/(due diligence) of in-licensing and acquisition targets • Developing a new, orthopedic indication for P32 (a therapeutic radio-pharmaceutical)• The compassionate use program for Therapeutic OctreoScan • Key opinion leader relations • Long range planning• Sales training

Doctor Of Medicine (Md)

Activities and Societies: Psychology Teaching Assistant, Department of Medical Psychology; Class representative to curriculum planning.

Mba

Activities and Societies: Beta Gamma Sigma Honor Society